Skip to main content
Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
101.27
+1.18 (1.18%)
At close: Feb 27, 2026, 4:00 PM EST
99.61
-1.66 (-1.64%)
After-hours: Feb 27, 2026, 7:54 PM EST

Incyte Revenue

In the year 2025, Incyte had annual revenue of $5.14B with 21.22% growth. Incyte had revenue of $1.51B in the quarter ending December 31, 2025, with 27.84% growth.

Revenue (ttm)
$5.14B
Revenue Growth
+21.22%
P/S Ratio
3.92
Revenue / Employee
$1,807,750
Employees
2,844
Market Cap
20.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.14B900.03M21.22%
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Genmab 3.72B
BioNTech SE 3.70B
Royalty Pharma 2.38B
Moderna 1.94B
Ionis Pharmaceuticals 944.00M
Ascendis Pharma 845.52M
Insmed 606.42M
BridgeBio Pharma 502.08M
Revenue Rankings

INCY News

More News